{"acquisitions":[],"changes":[{"companyHref":"/c/vimatx-com","date":"2026-10-03","documentUrl":"https://atlasventure.com/portfolio/","domain":"vimatx.com","fact":"provenance:existence","name":"Vima Therapeutics","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":"vimatx.com","status":"self-reported","url":"https://vimatx.com"},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-03","slug":"vimatx-com","status":"sourced","url":"https://whoraisedwhat.com/c/vimatx-com"},{"companyHref":"/c/vimatx-com","date":"2026-10-02","documentUrl":"https://atlasventure.com/portfolio/","domain":"vimatx.com","fact":"provenance:investor:atlas-venture","name":"Vima Therapeutics","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-02","slug":"vimatx-com","status":"sourced","url":"https://whoraisedwhat.com/c/vimatx-com"}],"country":"US","description":"Vima Therapeutics is a biopharma developing an oral therapy for movement disorders, starting with dystonia and Parkinson's. It serves patients with these conditions, which affect over a million people in the US. Its approach targets the underlying disease biology, and it is running the Stride dystonia study.","domain":"vimatx.com","employees":null,"founded":2023,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":["atlas-venture"],"lat":52.197585,"lng":0.139154,"location":"Cambridge","multiples":[],"name":"Vima Therapeutics","nameSource":{"publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},"people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":40000000,"connectionsAmong":[],"currency":"USD","date":"2026-03-10","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"vimatx-com-2026-03-10-series-a","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-19","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"vimatx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-19","status":"attributed","url":null},{"fact":"existence","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"description","publisher":"vimatx.com","retrievedAt":"2026-10-03","status":"self-reported","url":"https://vimatx.com"},{"fact":"investor:atlas-venture","publisher":"Atlas Venture","retrievedAt":"2026-10-02","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"stage":"series-a","stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"Atlas Venture\", \"role\": \"portfolio\", \"slug\": \"atlas-venture\", \"sources\": [{\"publisher\": \"Atlas Venture\", \"retrievedAt\": \"2026-10-02\", \"status\": \"sourced\", \"url\": \"https://atlasventure.com/portfolio/\"}]}","kind":"investor","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-10-02","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"text":"Vima Therapeutics was listed in Atlas Venture's portfolio, recorded 2026-10-02."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"Atlas Venture","role":"portfolio","slug":"atlas-venture","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-10-02","status":"sourced","url":"https://atlasventure.com/portfolio/"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","WordPress","Yoast SEO 27.6","Google Analytics","Google Tag Manager","Slick","jQuery Migrate 3.4.1","DoubleClick Floodlight","Cloudflare Bot Management","WP Engine","PHP","MySQL"],"totalRaisedUsd":40000000,"traction":[],"updatedAt":"2026-10-03","valuations":[]}